Potential CD34 signaling through phosphorylated-BAD in chemotherapy-resistant acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential CD34 signaling through phosphorylated-BAD in chemotherapy-resistant acute myeloid leukemia

Published:2019-05-04 Issue:3 Volume:39 Page:276-282
ISSN:1079-9893
Container-title:Journal of Receptors and Signal Transduction
language:en
Short-container-title:Journal of Receptors and Signal Transduction

Author:

Yiau Stephnie Kang-Xian¹,Lee CinDee²,Mohd. Tohit Eusni Rahayu¹,Chang Kian Meng³,Abdullah Maha¹²

Affiliation:

1. Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia;

2. Institute of Bioscience, Universiti Putra Malaysia, Serdang, Malaysia;

3. Department of Hematology, Hospital Ampang, Jalan Mewah Utara, Ampang, Malaysia

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10799893.2019.1660899

Reference39 articles.

1. Therapeutic Advances in Acute Myeloid Leukemia

2. The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells

3. The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators

4. Novel functions of the CD34 family

5. Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cells;OncoImmunology;2024-07-27

2. Emerging role of BAD and DAD1 as potential targets and biomarkers in cancer (Review);Oncology Letters;2021-09-28

3.

Combined Expression of CD34 and FLT3-Internal Tandem Duplication Mutation Predicts Poor Response to Treatment in Acute Myeloid Leukemia

;International Journal of General Medicine;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3